Get started
Author

Runzi Yang

Observed name: Run-Zi Yang
ORCID: 0009-0000-5043-6660
Observed ORCID: 0009-0000-5043-6660
OpenAlex ID: A5033026748
Efficacy and safety of anlotinib as a third‑line treatment of advanced non‑small cell lung cancer: A meta‑analysis of randomized controlled trials
2022 · Bowen Zha, Yuxin Zhang, et al. · Oncology Letters · 7
PDF
Long-term clinical course and recurrence pattern of orbital Kimura’s disease: a retrospective case series
2026 · Runzi Yang, Tingting Ren, et al. · BMC Ophthalmology · 1
Orbital Oncocytic Carcinoma: A Comprehensive Case Series and Literature Review
2024 · Jing Li, Runzi Yang, et al. · Ophthalmic Plastic and Reconstructive Surgery · 1
Sebaceous hyperplasia of the eyelid: A comprehensive case report and literature review
2024 · Mingshen Ma, Rui Liu, et al. · Heliyon · 1
Clinical features and prognosis of carcinoma ex pleomorphic adenoma of the lacrimal gland: a comprehensive case series and literature review
2025 · Run-Zi Yang, Rui Liu, et al. · International Journal of Ophthalmology
Development and evaluation of a quality-of-life questionnaire for patients with orbital malignant tumours
2025 · Haihan Yan, Junlian Lang, et al. · BMJ Open Ophthalmology
PDF
Works count: 6
Citation count: 10
H-index: 1
I10-index:
Year
Topic
Type